{"data":{"id":"us-dc/d.c.-code-48-841.02","jurisdiction":"us-dc","citation":"D.C. Code § 48-841.02","heading":"Definitions.","body":"For the purposes of this chapter, the term:\n\n(1)\n“FDA” means the federal Food and Drug Administration.\n\n(2)\n“Off-label use” means the use of a prescription drug for human use to treat a condition that is not included in the labeling for that medication, as approved by the federal Food and Drug Administration.\n\n(3)\n“Prescriber” means a person who is licensed, registered, or otherwise authorized by the District to prescribe and administer prescription drugs for human use in the course of a professional practice.","path":["Title 48. Foods and Drugs.","Chapter 8B. Off-Label Informed Consent."],"source_url":"https://code.dccouncil.gov/us/dc/council/code/sections/48-841.02","current_through":"2026-08-20 (D.C. Law 26-175)","vintage":"","retrieved_at":"2026-08-29T05:44:07Z","sha256":"90cfe173567bffdde995f7b4ba6eb39567f939b984d4cb19447d1c24e2a030b3","source_id":"us-dc","stale":false,"prev":"us-dc/d.c.-code-48-841.01","next":"us-dc/d.c.-code-48-841.03"},"notice":"GroundRules: Original legal text. Not legal advice."}